Iambic Therapeutics IPO

Iambic Therapeutics, based in San Diego, redefines drug discovery by combining human ingenuity with the power of AI. Emphasizing AI-driven design and automation, the company is a pioneer in creating data-efficient, physics-informed AI models. Iambic Therapeutics achieves more reliable and accurate modeling by incorporating physics principles into AI architectures, enabling deeper exploration in chemical space and accelerating the journey toward innovative medical solutions.

Register for Details

For more details on financing and valuation for Iambic Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Iambic Therapeutics

Forge green plus iconForge green minus icon

What is Iambic Therapeutics's IPO price?

The IPO price for Iambic Therapeutics will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Iambic Therapeutics?

Iambic Therapeutics is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Iambic Therapeutics shares pre-IPO?

If you own Iambic Therapeutics pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Iambic Therapeutics a publicly traded company?

Iambic Therapeutics is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

What is Iambic Therapeutics's funding to date?

Iambic Therapeutics has raised $227.9MM to date.
Forge green plus iconForge green minus icon

When was Iambic Therapeutics founded?

Iambic Therapeutics was founded in 2019.

Who are Iambic Therapeutics's major investors?

Sequoia Capital
Tao Capital Partners
Coatue Management
Nexus Venture Partners
NVIDIA
Abingworth
OrbiMed
Catalio Capital Management
Ascenta Capital
Illumina Ventures
FreeFlow

Iambic Therapeutics funding rounds and last known valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation
6/18/2024

Series B-2

$50MM raised $XXX.XX $XXX.XX
10/3/2023

Series B

$106.23MM raised $XXX.XX $XXX.XX
7/14/2021

Series A and A-1

$69.15MM raised $XXX.XX $XXX.XX
4/1/2020

Series Seed

$2.52MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: Jun 22, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.